PharmiWeb.com - Global Pharma News & Resources

Articles

At times of global economic downtown, and internal restructuring within firms, risks to innovation arise. And as businesses look for savings, research and development is seldom exempt.
At times of global economic downtown, and internal restructuring within firms, risks to innovation arise. And as businesses look for savings, research and development is seldom exempt. Last year for example, GlaxoSmithKline made considerable cuts to its research budget for mental health and other firms trimmed R&D substantially too, as even the greatest giants of the industry sought to respond to the impending expiration of patents and bleak pipelines ahead. In addition, while the greatest challenges remain endogenous, the long-held notion that the pharmaceutical world is entirely immune to wider financi…
As a result of a vote taken in the European Parliament earlier this week, patients in the European Union will receive improved information on prescription drugs, in addition to being protected from some of the more potentially exploitable clauses of the Commission’s proposed Directive on Information to Patients.
As a result of a vote taken in the European Parliament earlier this week, patients in the European Union will receive improved information on prescription drugs, in addition to being protected from some of the more potentially exploitable clauses of the Commission’s proposed Directive on Information to Patients. Specifically, and in contrast to proposals put forward by the Commission, the Parliament’s version of the bill makes it mandatory for drugs companies to provide both adequa…
In an age of competition and choice, patient knowledge is paramount. Between 1997 and 2007, the Blair government’s entire programme of public sector reforms were delivered under the banner of ‘Choice and Competition’.
In an age of competition and choice, patient knowledge is paramount. Between 1997 and 2007, the Blair government’s entire programme of public sector reforms were delivered under the banner of ‘Choice and Competition’. Where foundation hospitals provided the mechanism in the health service, city academies become the chosen instrument for education. Yet while Mr. Blair was ultimately shackled by the forces of the left within his party, the current government has no such obstacles in its way. Yet even if the new government is to succeed where the previous administration failed…
With the global economy remaining stagnant, big pharma companies are keen to develop blockbuster drugs that have a high financial ceiling. Rodger McMillan, VP of R&D at Astra Zeneca has said that “big pharma is a cash-rich industry – it has to be,” namely because of the huge costs in developing new drugs – sometimes as much as $200 million.
With the global economy remaining stagnant, big pharma companies are keen to develop blockbuster drugs that have a high financial ceiling. Rodger McMillan, VP of R&D at Astra Zeneca has said that “big pharma is a cash-rich industry – it has to be,” namely because of the huge costs in developing new drugs – sometimes as much as $200 million. However major change is championed by the illustrious NGP20 consortium chaired by Ted Torphy, the VP & Hea…
In the USA alone, when your neighbor is out of work it is a slowdown, when your family member is added it becomes recession and when you too join the same line than it surely becomes a depression. The unofficial employment in USA being claimed at 15-25 percent while the economical turnaround seems a mirage; the closer you get the clearer becomes the reality, nothing but refractions.
In the USA alone, when your neighbor is out of work it is a slowdown, when your family member is added it becomes recession and when you too join the same line than it surely becomes a depression. The unofficial employment in USA being claimed at 15-25 percent while the economical turnaround seems a mirage; the closer you get the clearer becomes the reality, nothing but refractions. The Internet civilization…
16-Nov-2010
In many ways, the National Institute for Health and Clinical Excellence (NICE) embodies many of the characteristics that define the NHS. In a system of universal access — and in a world where resources are finite — tough decisions inevitably have to be made. And by taking difficult decisions, particularly in reference to end of life care, NICE attempts to make the most of the drugs budget we do have.
In many ways, the National Institute for Health and Clinical Excellence (NICE) embodies many of the characteristics that define the NHS. In a system of universal access — and in a world where resources are finite — tough decisions inevitably have to be made. And by taking difficult decisions, particularly in reference to end of life care, NICE attempts to make the most of the drugs budget we d…
Epratuzumab, a new humanised IgG1 monoclonal antibody that acts on CD22 (a molecule preventing over-activation of the immune system and emergence of auto-immune diseases) has shown promise as a potential treatment of moderate to severe systemic lupus erythematosus (SLE) according to results of a new study EMBLEM.
Epratuzumab, a new humanised IgG1 monoclonal antibody that acts on CD22 (a molecule preventing over-activation of the immune system and emergence of auto-immune diseases) has shown promise as a potential treatment of moderate to severe systemic lupus erythematosus (SLE) according to results of a new study EMBLEM. Data from the phase IIB study involving 227 patients who received epratuzumab in a range of doses or placebo, were presented at the annual American Congress of Rheumatolog…
Large pharma has been seeking new biomarkers for years – all part of their drug discovery process, but often only as an afterthought in the development process. That’s changed over recent years, but by-and-large the bulk of biomarker work remains in the hands of small -to -medium-sized companies whose focused approach is more attuned to biomarkers being a major element of a final product.
Large pharma has been seeking new biomarkers for years – all part of their drug discovery process, but often only as an afterthought in the development process. That’s changed over recent years, but by-and-large the bulk of biomarker work remains in the hands of small -to -medium-sized companies whose focused approach is more attuned to biomarkers being a major element of a final product. Pharmaceutical…
As patients and prescribers increasingly move online for their information, how can pharma engage these audiences by incorporating digital marketing into their current plans?
Attend this free online summit hosted by BrightTALK to interact with leading experts from the world of pharma and digital marketing and stay ahead of the latest developments within healthcare marketing. You will be able to submit real-time questions to the presenters and vote in audience polls during the LIVE webcasts. If you are unable to attend the webcasts live, you can also view it afterward on demand. Click here to register for the summit: http://www.brighttalk.com/r/Mxf or view the webcast directly on PharmiWeb by clicking on the ‘attend’ or ‘play’ button on the player below.
Most pharmacologists will acknowledge that nutrition is important for good health and well-being, however, at the same time it is also considered to be a chemical nightmare with unknown effects. This has not always been the case, in the past connections between pharmacology and nutrition has been more intimate, as Hippocrates once stated, ‘‘Let food be thy medicine and let medicine be thy food.
Most pharmacologists will acknowledge that nutrition is important for good health and well-being, however, at the same time it is also considered to be a chemical nightmare with unknown effects. This has not always been the case, in the past connections between pharmacology and nutrition has been more intimate, as Hippocrates once stated, ‘‘Let food be thy medicine and let medicine be thy food. Only…
Reshaping the pharmaceutical industry's quality standards is currently the top priority for the Chinese government. Earlier announcements by its Ministry of Health to issue new tougher Good Manufacturing Processes (GMP) standards for medical products comes at the right time as current regulations do not meet international standards which result in poor performance by Chinese companies in the international market.
Reshaping the pharmaceutical industry's quality standards is currently the top priority for the Chinese government. Earlier announcements by its Ministry of Health to issue new tougher Good Manufacturing Processes (GMP) standards for medical products comes at the right time as current regulations do not meet international standards which result in poor performance by Chinese compa…
Now more than ever, alternative science and holistic remedies are playing a role in our lifestyles. But is that right? Over the past year, we've reported on everything from homeopathy to hypnotherapy. Importantly, we've differentiated between those approaches with at least a modicum of evidence to support them, and those without almost any at all. Yet in contrast to homeopathy, perhaps it can be said that our next target has at least a little science to support it.
Now more than ever, alternative science and holistic remedies are playing a role in our lifestyles. But is that right? Over the past year, we've reported on everything from homeopathy to hypnotherapy. Importantly, we've differentiated between those approaches with at least a modicum of evidence to support them, and those without…
Last week Pharmaceutical heads met as a result of a drugs recall after a pill mix up of breast cancer pills. The drug, Fresenius Kabi’s Anastrozole, was made by the German company’s subsidiary in India. The ingredient mix up led to the voluntary recall of 7,192 bottles, each containing 30 tablets.
Last week Pharmaceutical heads met as a result of a drugs recall after a pill mix up of breast cancer pills. The drug, Fresenius Kabi’s Anastrozole, was made by the German company’s subsidiary in India. The ingredient mix up led to the voluntary recall of 7,192 bottles, each containing 30 tablets.The mishap raises the question: Is there enough regulation to protect patients? As a new generation of bio pharmaceuticals go under trial in India those in attendance at the NGP EU summit were concer…
HealthcarePromotions.co.uk was created to provide UK healthcare professionals and students with a website for all their health promotion resources and news.
HealthcarePromotions.co.uk was created to provide UK healthcare professionals and students with a website for all their health promotion resources and news. It is free, easy to access and quick to use, saving the user valuable time whilst creating health awareness campaigns. To date, the website lists over 770 links to various health promotion resources such as patient leaflets, booklets and posters covering over 100 different health categories and over 7,600 medications. Contributions from NHS organisations, government agencies, WHO, national charities and the pharmaceutical industry ensures that only reliable resources are accessibl…
As Republican Congressmen line up to attack Barack Obama’s landmark U.S. healthcare reforms ahead of next month’s mid-term elections, reforms on this side of the Atlantic are receiving equally forceful criticism.
As Republican Congressmen line up to attack Barack Obama’s landmark U.S. healthcare reforms ahead of next month’s mid-term elections, reforms on this side of the Atlantic are receiving equally forceful criticism. Yet while Americans continue to debate the fundamental virtues of insuring all of its citizens, in Britain we are simply focussed on funding our National Health Service for the future. But that’s not to say that the debate isn’t equally as fierce. At least from one angle, the government’s argument for reform of the health service is solid. Namely, even with the Departme…
Out there on the branding battlefields its simply do or die as brand images are either hyper visible or mortally lost in oblivion. Commanding success for any idea on the global scene demands universal access on e-commerce that is only deliverable by a cyber name identity, as it's the only key to open the site.
Out there on the branding battlefields its simply do or die as brand images are either hyper visible or mortally lost in oblivion. Commanding success for any idea on the global scene demands universal access on e-commerce that is only deliverable by a cyber name identity, as it's the only key to open the site. Without it, accessibility to any cyber empire is simply doomed, dragging expansion dreams into cyber oblivion. Millions of million-dollar websites have slipped into the abyss,…
The Kingdom of Saudi Arabia provides a new opportunity for clinical research, and can open doors to untapped populations, explains Rani Abraham at ClinTec International
Recently, there has been a definite increase in the potential for investment in the clinical trials sector in the Kingdom of Saudi Arabia (KSA). Certain reforms in the sector such as the establishment of the Saudi Food and Drug Authority (SFDA)and the growth of the local pharmaceutical and healthcare industries, in combination with the growing importance of data from different races or ethnic populations, have made KSA an attractive country for conducting clinical trials. In the last decade, ethnicity and socio-economic differences in relation to disease incidence, diagnosis and prognosis have attracted attention. The inclus…
With access, cost and quality concerns plaguing pharmaceutical delivery systems both in the US as well as globally, the Next Generation Pharmaceutical Drug Discovery committee has been formed to confront, assess and deliver new strategies to secure the future of the industry.
With access, cost and quality concerns plaguing pharmaceutical delivery systems both in the US as well as globally, the Next Generation Pharmaceutical Drug Discovery committee has been formed to confront, assess and deliver new strategies to secure the future of the industry. Meeting in Miami, Florida, the committee will discuss the state-of-play for personalized medicine, R&D challenges, translational medicine, imaging techniques and novel biomarkers – all connected by the pulse of the sector: the call for open i…
If you have been looking around for a CV writing service you will have noticed that prices vary considerably and may be wondering why. The CV & Interview Advisors (that’s us) were one of the early entrants into the world of CV writing and have been around for many years.
If you have been looking around for a CV writing service you will have noticed that prices vary considerably and may be wondering why. The CV & Interview Advisors (that’s us) were one of the early entrants into the world of CV writing and have been around for many years. We consider ourselves an authority on our industry and all things related to job hunting and would like to shed some light on this issue.For us, it is a simple question of economics; a CV (if done properly) takes a few hours to write, we estimate betwe…
Over the last few years, many companies have started to offer CV appraisals to the extent that the market is now flooded with offers of free advice. I remember the days when we and one or two other CV writing companies offered such a service and it became a very effective way of building relationships with customers and strutting our expertise on all things CV related.
Over the last few years, many companies have started to offer CV appraisals to the extent that the market is now flooded with offers of free advice. I remember the days when we and one or two other CV writing companies offered such a service and it became a very effective way of building relationships with customers and strutting our expertise on all things CV related. Now it seems that every man and his dog is an expert on C…